News

Two CPR Strategies Fail to Improve Outcomes After Cardiac Arrest

View on the News

Systemic Changes in CPR Protocols May Yield Better Results

The findings of these "extremely well-performed," high-level scientific inquiries show that it may be more useful to consider out-of-hospital cardiac arrest as a public health problem rather than as a disease process, Dr. Arthur B. Sanders said.

And "randomized, controlled trials may not be the best strategy for making progress in the management of public health problems." After all, the efficacy of closed-chest compression, mouth-to-mouth rescue breathing, layperson-administered CPR, and prehospital defibrillation by EMS "were all major clinical advances ... that were not subjected to randomized clinical trials," he noted.

An alternative strategy of making systemic changes in standard CPR protocols nearly tripled the survival rate after cardiac arrest in Arizona, and the same model achieved similar survival benefits when used in rural Wisconsin, Dr. Sanders said.

Dr. Sanders, M.D., is in the department of emergency medicine at the University of Arizona’s Sarver Heart Center, Tucson. He reported no financial conflicts of interest. These remarks were taken from his editorial accompanying the reports by Dr. Stiell and Dr. Aufderheide (N. Engl. J. Med. 2011;365:850-1).


 

FROM THE NEW ENGLAND JOURNAL OF MEDICINE

These studies were funded by the U.S. National Heart, Lung, and Blood Institute; the U.S. National Institute of Neurological Disorders and Stroke; the Canadian Institutes of Health Research; and the Heart and Stroke Foundation of Canada. The authors and their associates reported ties to Medtronic, Philips Health Care, Amgen, Johnson & Johnson, Roche, Laerdal, Lifebridge, Zoll Medical, Imricor Medical Systems, Jolife, and the American Medical Association. Dr. Sanders reported no financial conflicts of interest.

Pages

Recommended Reading

Dalcetrapib Boosts HDL Without Bumping BP
MDedge Internal Medicine
Apixaban Beat Warfarin Regardless of Warfarin-Treatment Quality
MDedge Internal Medicine
Apixaban Scores on Efficacy and Safety Over Warfarin in AF
MDedge Internal Medicine
Eplerenone Effective Across All High-Risk Heart Failure Patients
MDedge Internal Medicine
ICDs: Home Monitoring May Cut Inappropriate Shocks
MDedge Internal Medicine
Survival Better in Women Post TAVI
MDedge Internal Medicine
Balloon Therapy Fails to Reduce Infarct Size
MDedge Internal Medicine
Reigning Coronary DES King Matches Its Predecessor
MDedge Internal Medicine
More Exercise, More Atrial Fibrillation in Men
MDedge Internal Medicine
Blood in the Streets of Paris
MDedge Internal Medicine